Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Photo of John McDermott
Person

John McDermott

Overview

Edit Overview Section
Number of Current Board & Advisor Roles 1
CB Rank (Person) 664,172
John McDermott is the CEO of Vascular Therapies.

Jobs

Edit Jobs Section
Number of Current Jobs 1
Number of Past Jobs 4
John McDermott is the CEO at Vascular Therapies. Additionally, John McDermott has had 4 past jobs including CEO & Board of Directors at Endologix.
Organization Name  
Title At Company  
Start Date  
End Date  
Endologix Logo
Endologix
CEO & Board of Directors20082018
C. R. Bard Logo
C. R. Bard
President, Bard Peripheral Vascular20022007
C. R. Bard Logo
C. R. Bard
President of Global Sales, Bard Peripheral Vascular20002002
C. R. Bard Logo
C. R. Bard
President, IMPRA Division19962000

Board and Advisor Roles

Edit Board and Advisor Roles Section
Number of Current Board & Advisor Roles 1
John McDermott is the Board Director at Entellus Medical.

Education

Edit Education Section
John McDermott studied at Arizona State University and  Western International University.

Recent News and Activity

Edit Recent News and Activity Section
Number of News Articles 12
News•Sep 14, 2020
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Jun 23, 2020
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Apr 9, 2020
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Feb 6, 2020
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Jul 24, 2019
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Jun 12, 2019
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•May 23, 2019
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Mar 23, 2019
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Jul 26, 2017
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•May 4, 2017
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
View All
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(3237dbc 1)
|